Novartis Investigative Site

Novi, Michigan 48375

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Atherosclerosis

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma — Completed